NEW YORK (GenomeWeb) – Pacific Biosciences said after the close of the market on Monday that it plans to sell shares of its common stock in a public offering.

The Menlo Park, California-based maker of sequencing platforms did not disclose the number of shares it planned to sell or how much money it expects to raise. The offering is pursuant to a $150 million shelf offering declared effective in August 2017.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.

The New York Times and ProPublica look into the close relationship between a startup and Memorial Sloan Kettering Cancer Center.

Yahoo News reports millions of dollars are being transferred from NIH, CDC, and other programs to pay for the housing of detained undocumented immigrant children.

Researchers gave a handful of octopuses MDMA to find that they too act more social on the drug, Gizmodo reports.

In Science this week: in vitro generation of human reproductive cells, and more.